510(k) K243725
K243725 is an FDA 510(k) premarket notification submitted by Becton, Dickinson And Company for the device "BD Vaginal Panel". The FDA issued a decision of Substantially Equivalent on Dec 19, 2024. The device falls under product code PQA (Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System), a Class II device regulated under 21 CFR 866.3975. Becton, Dickinson And Company has 330 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 19, 2024
- Date Received
- Dec 3, 2024
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System
- Device Class
- Class II
- Regulation Number
- 866.3975
- Review Panel
- MI
- Submission Type
- 510(k)
A vaginitis and bacterial vaginosis nucleic acid detection system is a qualitative in vitro diagnostic device for the direct detection of nucleic acid sequences from microorganisms associated with vaginitis or bacterial vaginosis. The device is indicated for individuals with signs and symptoms of vaginitis or bacterial vaginosis and aids in the diagnosis of these vaginal infections.
Need the full FDA record for Becton, Dickinson And Company? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.